Takip et
Nicholas A. Popp
Nicholas A. Popp
Medical Scientist Training Program, University of Washington
uw.edu üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs
JC Rose, NA Popp, CD Richardson, JJ Stephany, J Mathieu, CT Wei, ...
Nature communications 11 (1), 2697, 2020
722020
The role of sex in uveitis and ocular inflammation
IYL Yeung, NA Popp, CC Chan
International ophthalmology clinics 55 (3), 111-131, 2015
452015
High efficiency CRISPR/Cas9-mediated gene editing in primary human T-cells using mutant adenoviral E4orf6/E1b55k “helper” proteins
KS Gwiazda, AE Grier, J Sahni, SM Burleigh, U Martin, JG Yang, NA Popp, ...
Molecular therapy 24 (9), 1570-1580, 2016
442016
Animal models of age-related macular degeneration and their translatability into the clinic
S Chen, NA Popp, CC Chan
Expert review of ophthalmology 9 (4), 285-295, 2014
302014
Deciphering the impact of genomic variation on function
Code of Conduct Committee (alphabetical by last name) Cody Sarah 33 Farrell ...
Nature 633 (8028), 47-57, 2024
21*2024
Functional single nucleotide polymorphism in IL−17A 3′ untranslated region is targeted by miR‐4480 in vitro and may be associated with age‐related macular …
NA Popp, D Yu, B Green, EY Chew, B Ning, CC Chan, J Tuo
Environmental and molecular mutagenesis 57 (1), 58-64, 2016
172016
Responses of Multipotent Retinal Stem Cells to IL‐1β, IL‐18, or IL‐17
S Chen, D Shen, NA Popp, AJ Ogilvy, J Tuo, M Abu-Asab, T Xie, CC Chan
Journal of Ophthalmology 2015 (1), 369312, 2015
162015
A chemically controlled Cas9 switch enables temporal modulation of diverse effectors
CT Wei, NA Popp, O Peleg, RL Powell, E Borenstein, DJ Maly, DM Fowler
Nature chemical biology 19 (8), 981-991, 2023
132023
Evaluating potential therapies in a mouse model of focal retinal degeneration with age-related macular degeneration (AMD)-like lesions
N Popp, XK Chu, D Shen, J Tuo, CC Chan
Journal of clinical & experimental ophthalmology 4 (5), 1000296, 2013
122013
Multiplex, multimodal mapping of variant effects in secreted proteins
NA Popp, RL Powell, MK Wheelock, KJ Holmes, BD Zapp, KM Sheldon, ...
bioRxiv, 2024.04. 01.587474, 2024
22024
No Sex Differences in the Frequencies of Common Single Nucleotide Polymorphisms Associated with Age-Related Macular Degeneration
NA Popp, E Agrón, GS Hageman, J Tuo, EY Chew, CC Chan
Current eye research 42 (3), 470-475, 2017
22017
Warfarin Exposure Leads to Loss of Binding of Emicizumab to Factor IX
KW Lannert, B Samelson-Jones, K Berk, NA Popp, JP Sheehan, ...
Blood 144, 3955, 2024
2024
Multiplexed Surface Tethering of Extracellular Proteins (MultiSTEP) Protocols
NA Popp, MK Wheelock, R Wang, RL Powell, DM Fowler
2024
Functional Assessment of VWD Type 2N Variants Using Mammalian Cell Displayed Surface-Tethered Von Willebrand Factor
KW Lannert, SN Fletcher, NA Popp, PA Christopherson, DJ Hampshire, ...
Blood 142, 2604, 2023
2023
Building multiplexed genomic tools for editing and interpreting human variation
NA Popp
University of Washington, 2023
2023
Comprehensive Characterization of Missense Variation in Coagulation Factor IX Reveals Features Necessary for Secretion and γ-Carboxylation
NA Popp, RL Powell, B Zapp, K Lannert, JM Johnsen, DM Fowler
Blood 140 (Supplement 1), 5582-5583, 2022
2022
Catalytically inactive truncated guide rna compositions and related methods for suppression of crispr/cas off-target editing
JC Rose, D James, D Fowler, N Popp
US Patent App. 17/144,944, 2021
2021
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–17